Combining the 31-gene expression profile test for cutaneous melanoma with the American Joint Committee on Cancer staging identifies the highest-risk patients with stage I-II disease. (2023). SKIN The Journal of Cutaneous Medicine, 7(4), s223. https://doi.org/10.25251/skin.7.supp.223